Most Recent
Liquidator admits ‘significant deficiencies’ and agrees to 10-year ban
Restructuring & Insolvency 2019-07-17 10:07 pm By Miklos Bolza

Veritas Advisory liquidator David Iannuzzi has admitted to “quite significant deficiencies” in his conduct as a liquidator and agreed to a 10-year ban from serving as an insolvency practitioner.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ban on Instagram selfie with Kylie Jenner would intrude on ‘personal freedom’, judge says
Intellectual Property 2019-07-17 6:19 pm By Amelia Birnie

A judge has refused to order the removal of a selfie photograph with model Kylie Jenner from the personal Instagram account of the former CEO of a trendy Australian sunglasses retailer, saying such an injunction would intrude on her “personal freedom”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Monster Energy takes another shot at blocking monster wheels trade mark
Intellectual Property 2019-07-17 4:28 pm By Cat Fredenburgh

Beverage giant Monster Energy has appealed a ruling that allowed a company associated with leading tyre retailer Bob Jane T-Mart to register trade marks for its Monster brand alloy wheels.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Condom maker Ansell settles SKYN trade mark spat
Intellectual Property 2019-07-17 1:37 pm By Amelia Birnie

Ansell has settled a dispute with a Perth cosmetic clinic over its proposed registration of the trade mark ‘SKYN Love The Skyn You’re In’, after the Australian rubber latex manufacturer argued it was substantially identical to four of its condom trade marks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Claims of stolen docs at heart of new suit against Pfizer over vaccine patent
Intellectual Property 2019-07-16 9:48 pm By Miklos Bolza

Merck Sharp & Dohme has claimed ownership of a Pfizer patent related to the blockbuster Prevnar 13 vaccine, after a doctor who moved between the pharmaceutical companies and is listed as an author on the patent allegedly accessed confidential Merck documents before jumping ship to Pfizer.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Subpoena not a ‘garden party invitation’: judge in pelvic mesh class action warns doctor groups
Class Actions 2019-07-16 8:05 pm By Amelia Birnie

A judge overseeing the pelvic mesh class action against Johnson & Johnson subsidiary Ethicon has questioned why three doctor’s professional bodies tried to negotiate court orders requiring them to hand over their member lists, agreeing the supboena was “not a garden party invitation”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

IOOF CFO slams disqualification case as ‘egregious’ example of impulsive enforcement
Financial Services 2019-07-16 5:12 pm By Amelia Birnie

Lawyers for IOOF chief financial officer David Coulter have dismissed APRA’s allegations that he breached his superannuation duties as commercially “naïve”, “absolutely desperate” and a “most egregious example” of impulsive regulatory enforcement action.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Chris Gayle defeats defamation appeal by publishers despite lawyer going ‘too far’ at trial
Appeals 2019-07-16 4:52 pm By Miklos Bolza

The publishers of the Sydney Morning Herald, The Age and The Canberra Times have lost an appeal of a $300,000 defamation award to cricketer Chris Gayle, despite the appeals court finding Gayle’s barrister had gone “too far” in his submissions to the jury.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Judge ‘troubled’ by bid to extend class closure order in UGL shareholder action
Class Actions 2019-07-15 10:26 pm By Christine Caulfield

A judge overseeing a class action against engineering company UGL has agreed to extend a class closure order to give the parties a second chance to resolve the case in mediation, but not without expressing concerns that the order did not have the intended effect of encouraging settlement at the first sit-down.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme loses key battle in trade mark case ahead of trial
Intellectual Property 2019-07-15 8:51 pm By Miklos Bolza

A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed by German law, settling a key question before a trade mark case between the two drug giants goes to trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?